Cancer Journey


VIDEOS

GRACE sat down with Dr. Marco Ruiz to discuss information regarding when and who to refer for hematopoietic cell transplantation (HCT) (¿Cuándo y para...

GRACE sat down with Dr. Marco Ruiz to discuss information regarding acute myeloid leukemia (AML) in elderly patients (Leucemia aguda mieloide (LMA) en...

GRACE sat down with Dr. Marco Ruiz to discuss information regarding inhibitory molecules like the programmed cell death protein 1 (PD1) and its ligand...

GRACE sat down with Dr. Marco Ruiz to discuss information regarding the role of surveillance imaging in indolent lymphomas and chronic lymphocytic...

GRACE sat down with Dr. Marco Ruiz to discuss information regarding all diffuse large B-cell lymphoma (DLBCL) and are they made equally ("¿Todos los...

ARTICLES

ONLINE COMMUNITY

RECENT POSTS

Spanish Blood Cancer Library - Are all diffuse large B-cell lymphoma (DLBCL) made equally?

Video

GRACE sat down with Dr. Marco Ruiz to discuss information regarding all diffuse large B-cell lymphoma (DLBCL) and are they made equally ("¿Todos los linfomas difusos de linfocitos B (DLBCL) están hechos iguales?"). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin).


 

We would like to thank the following company for their support of this program:

Spanish Blood Cancer Library - Are all diffuse large B-cell lymphoma (DLBCL) made equally?

Video
GRACE is pleased to present updates in blood cancer treatments for our Spanish Blood Cancer Library with Dr. Marco Ruiz.  Dr. Ruiz shares information regarding Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin)., specifically "Are all diffuse large B-cell lymphoma (DLBCL) made equally? (¿Todos los linfomas difusos de linfocitos B (DLBCL) están hechos iguales ?)".

Spanish Blood Cancer Library - What is the chimeric T cell receptors treatment against tumoral antigens (CAR-T)? and how does it work?

Video
GRACE sat down with Dr. Marco Ruiz to discuss information regarding the chimeric T cell receptors treatment against tumoral antigens (CAR-T) and how it works (¿Cuál es la terapia de receptores de linfocitos T quiméricos contra antígenos tumorales (CAR-T)? y ¿Cómo funciona ?).  
 
Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin).

Spanish Blood Cancer Library - What is the role of stem cell transplantation in 2016?

Video

For this series, GRACE sat down with Marco Ruiz, MD, an oncologist at Memorial Cancer Institute specializing in hematologic or blood cancers, including leukemia, lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis. He is also an experienced bone marrow transplant specialist and is active in cancer research.

 

Spanish Blood Cancer Library - What are the risks and benefits of Ibrutinib and Idelalisib?

Video
For this video on the risks and benefits of Ibrutinib Idelalisib, GRACE sat down with Marco Ruiz, MD, an oncologist at Memorial Cancer Institute specializing in hematologic or blood cancers, including leukemia, lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis. He is also an experienced bone marrow transplant specialist and is active in cancer research.

 

Progress in Understanding DNA Changes in Lymphoma

Article
Malignant Hematology


Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this disease. Such tests can identify lymphoma cells based on changes such as chromosome translocations or rearrangements or specific gene mutations. Some of these tests are already in use, and others are being developed. They may be used to:

How GRACE Helped

Video

Two of GRACE's earliest followers, Laya Dogmetchi and Jim Celebucki, talk about how the Global Resource for Advancing Cancer Education helps cancer patients and their families make informed decisions about their care.

Subscribe to Blood Cancer